September 21, 2021

The financing was led by D1 Capital Partners, and proceeds will be utilized to develop the company’s commercial infrastructure as well as support additional clinical research, product development, and manufacturing.

July 27, 2021

Cytrellis announced that the U.S. Food and Drug Administration has cleared their first proprietary product, the ellacor^® system with Micro-Coring^® technology, for the treatment of moderate to severe wrinkles in the mid to lower face.

January 7, 2021

Cytrellis was named a finalist in the prestigious Terra2 Solutions Skin Health Innovation Competition at the Winter Clinical Dermatology Conference Jan 16-24! The competition is for companies developing game-changing technologies for skin health.

April 27, 2020

As seen in Modern Aesthetics   

Industry veteran Wendy Lewis sat down with Karen Cronholm to find out what she has learned along her path to CEO of an emerging aesthetics company. They discuss Karen’s start in the aesthetics field, her mentors, advice for the industry’s rising stars and much more.

March 3, 2020

Cytrellis competed in “Innovation Shark Tank” during IMCAS’ Global Market Summit, and was named first runner-up for IMCAS Innovation of the Year and awarded IMCAS Promising Innovation 2020!

December 30, 2019

As seen in NewBeauty

New York dermatologist Doris Day, MD calls the fractional facelift the “most exciting and revolutionary of all of the new rejuvenation technology….ever!” According to Dr. Day, the treatment relies on micro-coring of skin—a technique where “anywhere from dozens to hundreds of tiny, full thickness cores of the skin are removed”—which leaves bridges of normal skin between them, “allowing for skin contraction and a veritable lift, without surgery and with very little downtime.”